METRONIDAZOLE TOPICAL

METRONIDAZOLE TOPICAL was reported 48103 times

METRONIDAZOLE TOPICAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 246 0.8119
1 APPENDICOLITH 294 0.7597
2 SLEEP DISORDER THERAPY 137 0.6919
3 ANTACID THERAPY 87 0.6692
4 ANALGESIC THERAPY 133 0.4143
5 DRUG THERAPY 121 0.3569
6 ANTICOAGULANT THERAPY 85 0.2993
7 CONGENITAL HIATUS HERNIA 58 0.2544
8 MALIGNANT MELANOMA STAGE 0 50 0.2392
9 BACTEROIDES INFECTION 50 0.1916
10 FEMALE GENITAL TRACT FISTULA 281 0.1644
11 TOXIC ENCEPHALOPATHY 647 0.1276
12 DYSMETRIA 62 0.1026
13 PROCTITIS 280 0.0999
14 RADICULOPATHY 263 0.0997
15 CEREBELLAR ATAXIA 93 0.0971
16 BLOODY DISCHARGE 103 0.0901
17 CEREBELLAR SYNDROME 194 0.0885
18 PANCREATITIS HAEMORRHAGIC 41 0.0884
19 PSEUDOMEMBRANOUS COLITIS 189 0.0846
20 HYPERPHOSPHATAEMIA 176 0.0818
21 CHRONIC SINUSITIS 293 0.0780
22 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 68 0.0734
23 REVERSIBLE AIRWAYS OBSTRUCTION 37 0.0728
24 BLOOD PHOSPHORUS INCREASED 196 0.0717
25 MACULAR DEGENERATION 853 0.0714
26 MEGACOLON 111 0.0706
27 INTERNATIONAL NORMALISED RATIO FLUCTUATION 146 0.0705
28 ABORTION INCOMPLETE 122 0.0655
29 POUCHITIS 53 0.0616
30 DYSBIOSIS 48 0.0585
31 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 60 0.0565
32 CLOSTRIDIUM DIFFICILE COLITIS 594 0.0560
33 PATHOGEN RESISTANCE 487 0.0534
34 FIXED ERUPTION 87 0.0505
35 LINEAR IGA DISEASE 84 0.0505
36 TOTAL LUNG CAPACITY DECREASED 80 0.0501
37 ACINETOBACTER INFECTION 53 0.0484
38 FISTULA DISCHARGE 61 0.0483
39 CLOSTRIDIUM COLITIS 58 0.0478
40 HYPERPARATHYROIDISM SECONDARY 114 0.0455
41 IRON DEFICIENCY 204 0.0453
42 DIARRHOEA INFECTIOUS 35 0.0444
43 NEPHROGENIC ANAEMIA 204 0.0440
44 CLOSTRIDIUM TEST POSITIVE 97 0.0440
45 IDIOSYNCRATIC DRUG REACTION 41 0.0418
46 CLOSTRIDIUM DIFFICILE INFECTION 901 0.0412
47 APPENDICITIS 385 0.0412
48 LARGE INTESTINE INFECTION 50 0.0407
49 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 58 0.0399
50 VANISHING BILE DUCT SYNDROME 43 0.0386
51 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 272 0.0350
52 TONGUE COATED 60 0.0347
53 NEUROTOXICITY 589 0.0336
54 WHITE MATTER LESION 42 0.0332
55 REBOUND ACID HYPERSECRETION 100 0.0330
56 KOUNIS SYNDROME 74 0.0326
57 ENTEROCOLITIS HAEMORRHAGIC 48 0.0324
58 CLOSTRIDIAL INFECTION 109 0.0322
59 BACTERIAL VAGINOSIS 50 0.0319
60 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 160 0.0316
61 VAGINAL DISCHARGE 307 0.0303
62 LYME DISEASE 101 0.0303
63 PELVIC INFLAMMATORY DISEASE 45 0.0301
64 BLOOD URIC ACID INCREASED 174 0.0301
65 BRAIN ABSCESS 76 0.0300
66 VENTRICULAR FIBRILLATION 332 0.0299
67 ORAL CANDIDIASIS 393 0.0298
68 ENTEROCOCCAL INFECTION 143 0.0296
69 GASTROINTESTINAL WALL THICKENING 43 0.0287
70 END STAGE RENAL DISEASE 517 0.0283
71 HYPOPHOSPHATAEMIA 208 0.0281
72 NEUTROPENIC COLITIS 58 0.0280
73 ATAXIA 332 0.0279
74 AORTIC STENOSIS 97 0.0278
75 ANAL ABSCESS 148 0.0274
76 LUNG OPACITY 72 0.0273
77 MULTIPLE ORGAN DYSFUNCTION SYNDROME 769 0.0271
78 ABSCESS INTESTINAL 58 0.0269
79 ANAL FISSURE 140 0.0261
80 RECTAL ABSCESS 43 0.0256
81 MYASTHENIA GRAVIS 206 0.0255
82 ANAL FISTULA 133 0.0249
83 ROSACEA 116 0.0249
84 FISTULA 278 0.0247
85 ABDOMINAL ABSCESS 109 0.0246
86 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 630 0.0245
87 PARAESTHESIA ORAL 344 0.0238
88 CARDIOGENIC SHOCK 342 0.0238
89 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 53 0.0237
90 KLEBSIELLA INFECTION 119 0.0235
91 PLEURITIC PAIN 64 0.0232
92 STRONGYLOIDIASIS 37 0.0229
93 FUNGAEMIA 36 0.0229
94 DIVERTICULAR PERFORATION 47 0.0228
95 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 59 0.0222
96 STENOSIS 41 0.0218
97 SYSTEMIC CANDIDA 54 0.0215
98 RASH MORBILLIFORM 59 0.0213
99 LONG QT SYNDROME 51 0.0213
100 TYPE IV HYPERSENSITIVITY REACTION 58 0.0212
101 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 48 0.0208
102 COLITIS 789 0.0208
103 CHOLESTATIC LIVER INJURY 46 0.0206
104 LIVER ABSCESS 67 0.0206
105 ENCEPHALOPATHY 498 0.0203
106 NYSTAGMUS 106 0.0200
107 HAEMOLYTIC URAEMIC SYNDROME 46 0.0198
108 TOXIC EPIDERMAL NECROLYSIS 296 0.0195
109 HEPATIC NECROSIS 70 0.0186
110 BONE EROSION 65 0.0184
111 CYTOMEGALOVIRUS COLITIS 42 0.0182
112 RETROPERITONEAL HAEMATOMA 39 0.0176
113 OPTIC NEUROPATHY 37 0.0175
114 BACTERIAL INFECTION 321 0.0172
115 SEPTIC SHOCK 735 0.0169
116 DRUG LEVEL BELOW THERAPEUTIC 93 0.0168
117 ASCITES 494 0.0168
118 VENOOCCLUSIVE LIVER DISEASE 82 0.0166
119 ABSCESS 261 0.0163
120 CHOLECYSTITIS CHRONIC 109 0.0163
121 HYPERLIPIDAEMIA 193 0.0161
122 BENIGN PROSTATIC HYPERPLASIA 83 0.0161
123 RASH MACULO-PAPULAR 356 0.0160
124 ABDOMINAL TENDERNESS 79 0.0159
125 TROPONIN INCREASED 121 0.0159
126 LARGE INTESTINE PERFORATION 110 0.0158
127 TONGUE DISCOLOURATION 69 0.0158
128 ACUTE PSYCHOSIS 39 0.0158
129 RENAL TUBULAR NECROSIS 153 0.0156
130 TENOSYNOVITIS 43 0.0156
131 CHRONIC KIDNEY DISEASE 1181 0.0155
132 DEAFNESS NEUROSENSORY 51 0.0155
133 DISTRIBUTIVE SHOCK 35 0.0154
134 PROCTALGIA 99 0.0154
135 TUBULOINTERSTITIAL NEPHRITIS 288 0.0154
136 AREFLEXIA 41 0.0153
137 HAEMODYNAMIC INSTABILITY 116 0.0152
138 FAECAL CALPROTECTIN INCREASED 48 0.0151
139 COLITIS ISCHAEMIC 102 0.0151
140 CHROMATURIA 334 0.0148
141 DIVERTICULUM INTESTINAL 64 0.0146
142 MUCOUS STOOLS 72 0.0145
143 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 47 0.0145
144 VAGINAL INFECTION 68 0.0144
145 FREQUENT BOWEL MOVEMENTS 390 0.0144
146 TORSADE DE POINTES 112 0.0143
147 LEUKOENCEPHALOPATHY 53 0.0142
148 PSEUDOMONAS INFECTION 122 0.0142
149 DIVERTICULITIS 389 0.0140
150 ECONOMIC PROBLEM 212 0.0140
151 ASPERGILLUS INFECTION 91 0.0139
152 SWOLLEN TONGUE 432 0.0138
153 ACUTE HEPATIC FAILURE 188 0.0137
154 RESPIRATORY SYMPTOM 39 0.0137
155 DERMATITIS EXFOLIATIVE GENERALISED 47 0.0135
156 CROHN'S DISEASE 92 0.0134
157 HYPERREFLEXIA 46 0.0132
158 BREATH SOUNDS ABNORMAL 64 0.0130
159 LOW BIRTH WEIGHT BABY 102 0.0128
160 EOSINOPHILIA 224 0.0128
161 BRONCHIECTASIS 86 0.0128
162 NECROTISING FASCIITIS 45 0.0128
163 CHOLESTASIS 245 0.0127
164 ADENOVIRUS INFECTION 37 0.0127
165 SUBCUTANEOUS ABSCESS 61 0.0127
166 PERIPHERAL SENSORY NEUROPATHY 74 0.0126
167 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 120 0.0126
168 CHOLECYSTITIS ACUTE 71 0.0125
169 CANDIDA INFECTION 211 0.0125
170 HEPATIC CYST 42 0.0124
171 AGRANULOCYTOSIS 227 0.0122
172 BLOOD CALCIUM INCREASED 107 0.0122
173 HAEMATOCHEZIA 672 0.0122
174 LEUKOCYTOSIS 220 0.0121
175 HEPATIC CYTOLYSIS 153 0.0120
176 WOUND COMPLICATION 41 0.0119
177 DISSEMINATED INTRAVASCULAR COAGULATION 168 0.0119
178 THROMBOTIC THROMBOCYTOPENIC PURPURA 42 0.0119
179 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 204 0.0119
180 HALLUCINATIONS, MIXED 50 0.0119
181 DIARRHOEA HAEMORRHAGIC 111 0.0119
182 ESCHERICHIA INFECTION 97 0.0118
183 DYSARTHRIA 441 0.0117
184 BACTERAEMIA 139 0.0117
185 HYPOVOLAEMIC SHOCK 56 0.0117
186 VASCULAR DEVICE INFECTION 53 0.0117
187 APLASTIC ANAEMIA 61 0.0117
188 PROCEDURAL PAIN 324 0.0117
189 APHTHOUS ULCER 90 0.0116
190 RECTAL HAEMORRHAGE 495 0.0115
191 ENTEROCOLITIS 66 0.0114
192 RHEUMATOID FACTOR POSITIVE 66 0.0114
193 COLITIS ULCERATIVE 504 0.0113
194 DIVERTICULUM 80 0.0112
195 ULCER 179 0.0112
196 ANHEDONIA 295 0.0112
197 HEPATITIS 287 0.0112
198 NEUTROPENIC SEPSIS 80 0.0112
199 PANCREATITIS ACUTE 251 0.0112
200 OLIGURIA 69 0.0111
201 NEUROLOGICAL SYMPTOM 63 0.0110
202 ARTERIOSPASM CORONARY 44 0.0110
203 RESPIRATORY ACIDOSIS 43 0.0109
204 DERMATITIS EXFOLIATIVE 54 0.0108
205 METABOLIC ACIDOSIS 341 0.0107
206 NEURALGIA 259 0.0106
207 NECROSIS 59 0.0106
208 RENAL CYST 84 0.0106
209 HYPOALBUMINAEMIA 82 0.0105
210 ERYTHEMA NODOSUM 37 0.0105
211 ILEUS PARALYTIC 47 0.0105
212 ABORTION SPONTANEOUS 417 0.0104
213 SEPSIS 1156 0.0104
214 ENTERITIS 66 0.0103
215 TYPE I HYPERSENSITIVITY 36 0.0102
216 HELICOBACTER INFECTION 105 0.0102
217 ANGIOEDEMA 448 0.0101
218 ACUTE KIDNEY INJURY 1542 0.0101
219 IMMUNE THROMBOCYTOPENIA 46 0.0100
220 AMYLASE INCREASED 37 0.0100
221 STAPHYLOCOCCAL INFECTION 328 0.0099
222 STAPHYLOCOCCAL SEPSIS 49 0.0099
223 HEPATITIS ACUTE 64 0.0098
224 NEPHROPATHY TOXIC 110 0.0098
225 SMALL INTESTINAL OBSTRUCTION 120 0.0097
226 WOUND SECRETION 38 0.0097
227 ANAPHYLACTIC REACTION 536 0.0097
228 RALES 56 0.0096
229 SKIN NECROSIS 50 0.0096
230 INTESTINAL PERFORATION 108 0.0096
231 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 72 0.0096
232 HYPONATRAEMIA 536 0.0095
233 RED BLOOD CELL SEDIMENTATION RATE INCREASED 105 0.0095
234 GOUT 170 0.0095
235 HYPERNATRAEMIA 47 0.0094
236 HYPERACUSIS 35 0.0094
237 PROTHROMBIN TIME PROLONGED 56 0.0094
238 HEPARIN-INDUCED THROMBOCYTOPENIA 46 0.0093
239 GASTROINTESTINAL INFLAMMATION 73 0.0093
240 DRUG-INDUCED LIVER INJURY 292 0.0093
241 GINGIVAL SWELLING 41 0.0093
242 INTERNATIONAL NORMALISED RATIO INCREASED 264 0.0092
243 RASH PUSTULAR 67 0.0092
244 DRUG RESISTANCE 236 0.0092
245 ABSCESS LIMB 39 0.0091
246 ASPIRATION 100 0.0091
247 COAGULOPATHY 152 0.0091
248 ABDOMINAL PAIN 2119 0.0091
249 POLYNEUROPATHY 109 0.0091
250 ATELECTASIS 87 0.0090
251 BLOOD ALBUMIN DECREASED 71 0.0089
252 PERIPHERAL VASCULAR DISORDER 46 0.0089
253 RENAL FAILURE 1180 0.0089
254 C-REACTIVE PROTEIN ABNORMAL 57 0.0089
255 MATERNAL EXPOSURE DURING BREAST FEEDING 36 0.0089
256 CHOLECYSTITIS 105 0.0088
257 SWELLING FACE 572 0.0088
258 GRAFT VERSUS HOST DISEASE 63 0.0088
259 MALNUTRITION 98 0.0088
260 CANDIDIASIS 35 0.0087
261 DERMATITIS BULLOUS 63 0.0087
262 GASTROENTERITIS 127 0.0087
263 FULL BLOOD COUNT ABNORMAL 92 0.0087
264 STILLBIRTH 42 0.0087
265 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 475 0.0086
266 STEVENS-JOHNSON SYNDROME 192 0.0086
267 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 614 0.0086
268 SPRUE-LIKE ENTEROPATHY 42 0.0085
269 GASTROINTESTINAL INFECTION 76 0.0085
270 INFLAMMATORY MARKER INCREASED 42 0.0085
271 HEPATOMEGALY 83 0.0084
272 ENCEPHALITIS 58 0.0084
273 ACIDOSIS 64 0.0084
274 MUCOSAL INFLAMMATION 219 0.0084
275 HEPATIC FAILURE 251 0.0083
276 DRUG LEVEL ABOVE THERAPEUTIC 38 0.0083
277 HYPERCHOLESTEROLAEMIA 80 0.0083
278 DERMATITIS ALLERGIC 104 0.0083
279 DRUG INTOLERANCE 794 0.0082
280 ABDOMINAL DISTENSION 855 0.0082
281 ABNORMAL FAECES 67 0.0082
282 ANURIA 70 0.0081
283 LIVER FUNCTION TEST ABNORMAL 236 0.0081
284 MULTI-ORGAN FAILURE 140 0.0081
285 MENINGITIS ASEPTIC 36 0.0080
286 ELECTROLYTE IMBALANCE 93 0.0080
287 MENTAL STATUS CHANGES 222 0.0080
288 INTESTINAL ISCHAEMIA 44 0.0080
289 TACHYPNOEA 108 0.0079
290 BLOOD TEST ABNORMAL 111 0.0079
291 PAROSMIA 59 0.0078
292 HEPATITIS CHOLESTATIC 47 0.0078
293 ENDOCARDITIS 40 0.0078
294 OSTEOPENIA 118 0.0078
295 JAUNDICE 209 0.0078
296 TENDONITIS 120 0.0077
297 ERYTHEMA MULTIFORME 72 0.0077
298 RENAL INJURY 229 0.0077
299 UMBILICAL HERNIA 36 0.0077
300 PETECHIAE 80 0.0077
301 C-REACTIVE PROTEIN INCREASED 278 0.0076
302 MICTURITION URGENCY 87 0.0076
303 PREMATURE LABOUR 43 0.0076
304 PREMATURE DELIVERY 121 0.0076
305 BLOOD BILIRUBIN INCREASED 205 0.0076
306 LIPASE INCREASED 58 0.0076
307 CYTOMEGALOVIRUS INFECTION 125 0.0075
308 PREMATURE BABY 226 0.0075
309 BRONCHOPULMONARY ASPERGILLOSIS 58 0.0075
310 SECRETION DISCHARGE 93 0.0074
311 MANIA 122 0.0074
312 HIATUS HERNIA 96 0.0074
313 MOUTH SWELLING 42 0.0073
314 HAEMATOTOXICITY 69 0.0073
315 ILEUS 90 0.0072
316 HYPERBILIRUBINAEMIA 75 0.0072
317 MOUTH ULCERATION 152 0.0072
318 SPINAL OSTEOARTHRITIS 63 0.0072
319 TOXIC SKIN ERUPTION 72 0.0071
320 GENERALISED TONIC-CLONIC SEIZURE 118 0.0071
321 HIDRADENITIS 65 0.0071
322 MYOCLONUS 85 0.0071
323 POSTOPERATIVE WOUND INFECTION 48 0.0071
324 HYPOKALAEMIA 328 0.0071
325 HYPOXIA 248 0.0070
326 PANCYTOPENIA 391 0.0070
327 HEPATOCELLULAR INJURY 99 0.0070
328 ORAL DISORDER 51 0.0070
329 VASCULITIS 81 0.0069
330 PERIORBITAL OEDEMA 36 0.0069
331 DRUG INTERACTION 1098 0.0069
332 DRUG LEVEL DECREASED 70 0.0069
333 TOOTH ABSCESS 70 0.0069
334 PERITONITIS 142 0.0068
335 BLOOD ALKALINE PHOSPHATASE INCREASED 170 0.0068
336 STREPTOCOCCAL INFECTION 38 0.0068
337 BLEPHAROSPASM 43 0.0068
338 SERUM FERRITIN INCREASED 36 0.0068
339 LARGE INTESTINE POLYP 47 0.0068
340 ABDOMINAL PAIN LOWER 171 0.0068
341 PLATELET COUNT INCREASED 88 0.0067
342 FAILURE TO THRIVE 35 0.0067
343 ANAEMIA 1285 0.0067
344 NEUROPATHY PERIPHERAL 636 0.0067
345 PLEURAL EFFUSION 406 0.0067
346 CATATONIA 35 0.0067
347 PYREXIA 2288 0.0066
348 SHOCK 152 0.0066
349 IRON DEFICIENCY ANAEMIA 61 0.0066
350 ASPARTATE AMINOTRANSFERASE INCREASED 351 0.0066
351 TENDON DISORDER 43 0.0066
352 ACUTE RESPIRATORY DISTRESS SYNDROME 116 0.0066
353 TENDERNESS 68 0.0065
354 POST PROCEDURAL INFECTION 53 0.0065
355 GAMMA-GLUTAMYLTRANSFERASE INCREASED 144 0.0065
356 LEUKOPENIA 325 0.0065
357 RESPIRATORY FAILURE 473 0.0065
358 TENDON PAIN 49 0.0065
359 DRUG SPECIFIC ANTIBODY PRESENT 42 0.0065
360 ELECTROCARDIOGRAM QT PROLONGED 232 0.0064
361 GENERAL PHYSICAL HEALTH DETERIORATION 745 0.0064
362 COORDINATION ABNORMAL 89 0.0064
363 NERVOUS SYSTEM DISORDER 199 0.0064
364 TOOTH INFECTION 84 0.0064
365 SKIN WARM 37 0.0064
366 EXPOSURE DURING PREGNANCY 394 0.0063
367 PURPURA 56 0.0063
368 HYPERTRANSAMINASAEMIA 44 0.0063
369 HAEMORRHOIDS 123 0.0063
370 DERMATITIS ACNEIFORM 38 0.0062
371 VENTRICULAR TACHYCARDIA 103 0.0062
372 LUNG INFILTRATION 55 0.0062
373 CHOLELITHIASIS 204 0.0062
374 ODYNOPHAGIA 37 0.0062
375 OSTEOMYELITIS 112 0.0062
376 POOR VENOUS ACCESS 64 0.0062
377 DYSPHONIA 361 0.0062
378 IRRITABLE BOWEL SYNDROME 132 0.0062
379 UTERINE LEIOMYOMA 45 0.0062
380 HYPOVOLAEMIA 36 0.0061
381 SKIN ULCER 157 0.0061
382 INTERVERTEBRAL DISC DEGENERATION 56 0.0060
383 PULMONARY MASS 90 0.0060
384 DRUG LEVEL INCREASED 100 0.0060
385 OESOPHAGITIS 66 0.0060
386 PHARYNGEAL SWELLING 59 0.0060
387 LIVER INJURY 148 0.0060
388 HAEMOLYTIC ANAEMIA 54 0.0060
389 LIP SWELLING 200 0.0060
390 INFUSION RELATED REACTION 397 0.0060
391 CIRCULATORY COLLAPSE 102 0.0060
392 PRODUCT ADMINISTRATION INTERRUPTED 47 0.0060
393 POLYP 39 0.0060
394 DYSPEPSIA 586 0.0060
395 FEBRILE NEUTROPENIA 394 0.0059
396 TRANSAMINASES INCREASED 132 0.0059
397 DELIRIUM 206 0.0059
398 TRICUSPID VALVE INCOMPETENCE 47 0.0059
399 DYSGEUSIA 439 0.0059
400 SPUTUM DISCOLOURED 56 0.0059
401 HEPATIC ENCEPHALOPATHY 55 0.0059
402 HEPATOTOXICITY 131 0.0059
403 APPETITE DISORDER 39 0.0059
404 CARDIAC FLUTTER 38 0.0059
405 RESPIRATORY DISTRESS 162 0.0059
406 DRUG ERUPTION 104 0.0059
407 UROSEPSIS 54 0.0058
408 LOWER RESPIRATORY TRACT INFECTION 266 0.0058
409 MENINGITIS 39 0.0058
410 TONGUE DISORDER 42 0.0058
411 ALANINE AMINOTRANSFERASE INCREASED 356 0.0058
412 DEVICE RELATED INFECTION 89 0.0058
413 ANAL INCONTINENCE 52 0.0058
414 PULMONARY EMBOLISM 547 0.0058
415 ANAPHYLACTIC SHOCK 148 0.0057
416 FUNGAL INFECTION 191 0.0057
417 SEROTONIN SYNDROME 110 0.0057
418 SENSORY LOSS 46 0.0057
419 GALLBLADDER DISORDER 102 0.0057
420 EAR PAIN 111 0.0057
421 OSTEOPOROSIS 233 0.0057
422 SWELLING 529 0.0056
423 LIVER DISORDER 250 0.0056
424 SINUS TACHYCARDIA 80 0.0056
425 TACHYCARDIA 499 0.0056
426 BURSITIS 68 0.0056
427 GENERALISED OEDEMA 69 0.0056
428 PHOTOSENSITIVITY REACTION 92 0.0056
429 DEFAECATION URGENCY 39 0.0056
430 ACUTE RESPIRATORY FAILURE 107 0.0056
431 THROMBOCYTOPENIA 619 0.0055
432 DUODENAL ULCER 39 0.0055
433 SKIN LESION 151 0.0055
434 BLOOD CREATININE INCREASED 359 0.0055
435 LIVER FUNCTION TEST INCREASED 118 0.0055
436 OBSTRUCTIVE AIRWAYS DISORDER 61 0.0055
437 MATERNAL EXPOSURE DURING PREGNANCY 487 0.0055
438 RENAL FAILURE CHRONIC 42 0.0055
439 MELAENA 120 0.0054
440 WHITE BLOOD CELL COUNT INCREASED 209 0.0054
441 TREATMENT FAILURE 450 0.0054
442 CONSTIPATION 1183 0.0054
443 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 282 0.0054
444 CONDITION AGGRAVATED 1635 0.0054
445 FACIAL PAIN 48 0.0054
446 DISORIENTATION 213 0.0054
447 PHOTOPHOBIA 101 0.0054
448 CONFUSIONAL STATE 863 0.0053
449 FACE OEDEMA 90 0.0053
450 HYPOGAMMAGLOBULINAEMIA 35 0.0053
451 ALTERED STATE OF CONSCIOUSNESS 115 0.0053
452 FAECES DISCOLOURED 115 0.0053
453 GASTROOESOPHAGEAL REFLUX DISEASE 425 0.0053
454 OEDEMA 286 0.0053
455 INJURY 370 0.0053
456 URINE OUTPUT DECREASED 46 0.0053
457 LIVE BIRTH 44 0.0053
458 LIGAMENT SPRAIN 52 0.0053
459 RENAL FAILURE ACUTE 223 0.0052
460 HAEMODIALYSIS 44 0.0052
461 VITAMIN D DEFICIENCY 51 0.0052
462 BLOOD CHOLESTEROL INCREASED 243 0.0052
463 MITRAL VALVE INCOMPETENCE 59 0.0052
464 PARAESTHESIA 817 0.0052
465 CENTRAL NERVOUS SYSTEM LESION 71 0.0052
466 BLOOD PRESSURE FLUCTUATION 124 0.0052
467 INTENTIONAL PRODUCT USE ISSUE 452 0.0052
468 NIGHT SWEATS 166 0.0051
469 MYOCARDITIS 59 0.0051
470 PHARYNGEAL OEDEMA 79 0.0051
471 ORAL PAIN 114 0.0051
472 CORONARY ARTERY DISEASE 154 0.0051
473 CARDIAC MURMUR 44 0.0051
474 UTERINE PERFORATION 43 0.0051
475 HALLUCINATION, AUDITORY 80 0.0050
476 AUTOIMMUNE HEPATITIS 35 0.0050
477 CYANOSIS 79 0.0050
478 CELLULITIS 252 0.0050
479 VOMITING 2331 0.0050
480 HYDRONEPHROSIS 37 0.0049
481 APHASIA 149 0.0049
482 NEPHROPATHY 46 0.0049
483 THROMBOTIC MICROANGIOPATHY 48 0.0049
484 CHOLECYSTECTOMY 56 0.0049
485 OVARIAN CYST 49 0.0049
486 UNRESPONSIVE TO STIMULI 126 0.0049
487 PSYCHIATRIC SYMPTOM 36 0.0049
488 PARANOIA 84 0.0049
489 SINUS BRADYCARDIA 47 0.0049
490 RASH ERYTHEMATOUS 232 0.0048
491 HAEMATEMESIS 123 0.0048
492 LACTIC ACIDOSIS 156 0.0048
493 HYPOPHAGIA 123 0.0048
494 MUSCULOSKELETAL STIFFNESS 421 0.0048
495 INFLAMMATORY BOWEL DISEASE 47 0.0048
496 TINNITUS 220 0.0048
497 GASTRITIS 126 0.0048
498 DEEP VEIN THROMBOSIS 310 0.0048
499 OBESITY 76 0.0048
500 DRY MOUTH 386 0.0048
501 PSYCHOLOGICAL TRAUMA 41 0.0047
502 BLOOD PRESSURE DIASTOLIC DECREASED 35 0.0047
503 HAEMATOCRIT DECREASED 94 0.0047
504 FOETAL EXPOSURE DURING PREGNANCY 385 0.0047
505 INFECTION 685 0.0047
506 PNEUMOTHORAX 75 0.0047
507 SKIN INFECTION 53 0.0047
508 BONE DISORDER 86 0.0047
509 INTESTINAL OBSTRUCTION 177 0.0047
510 RASH MACULAR 164 0.0047
511 HYPOKINESIA 68 0.0047
512 DERMATITIS 98 0.0047
513 SCAR 80 0.0047
514 BODY TEMPERATURE DECREASED 46 0.0047
515 SHOCK HAEMORRHAGIC 38 0.0047
516 DECUBITUS ULCER 38 0.0047
517 ATRIAL SEPTAL DEFECT 39 0.0047
518 DYSURIA 171 0.0046
519 MUSCLE TWITCHING 107 0.0046
520 POLYURIA 38 0.0046
521 NEUTROPENIA 630 0.0046
522 HEAD DISCOMFORT 82 0.0046
523 SLEEP DISORDER 326 0.0046
524 BODY TEMPERATURE INCREASED 94 0.0046
525 NEUTROPHIL COUNT INCREASED 47 0.0046
526 THERAPY NON-RESPONDER 206 0.0046
527 PANCREATITIS 242 0.0046
528 HALLUCINATION 345 0.0046
529 PSYCHOTIC DISORDER 135 0.0046
530 PARKINSONISM 44 0.0045
531 RASH PAPULAR 101 0.0045
532 HALLUCINATION, VISUAL 95 0.0045
533 SUPRAVENTRICULAR TACHYCARDIA 43 0.0045
534 PNEUMONIA ASPIRATION 112 0.0045
535 BLOOD LACTATE DEHYDROGENASE INCREASED 71 0.0045
536 FLANK PAIN 42 0.0045
537 IMPAIRED GASTRIC EMPTYING 61 0.0045
538 PELVIC PAIN 81 0.0045
539 OSTEOARTHRITIS 189 0.0045
540 ORAL HERPES 87 0.0045
541 EMBOLISM 37 0.0045
542 HYPERSENSITIVITY 827 0.0045
543 SPLENOMEGALY 52 0.0044
544 THROMBOSIS 357 0.0044
545 DYSPHAGIA 421 0.0044
546 PHARYNGITIS 55 0.0044
547 STATUS EPILEPTICUS 50 0.0044
548 PARALYSIS 63 0.0044
549 BLISTER 247 0.0044
550 GINGIVAL PAIN 35 0.0044
551 HYPOMAGNESAEMIA 61 0.0044
552 NAUSEA 3460 0.0044
553 CARDIAC ARREST 360 0.0044
554 ERYTHEMA 892 0.0043
555 HAEMOPTYSIS 121 0.0043
556 GRAND MAL CONVULSION 40 0.0043
557 BONE MARROW FAILURE 88 0.0043
558 RESPIRATORY DEPRESSION 53 0.0043
559 CARDIOMEGALY 53 0.0043
560 HYPOTONIA 43 0.0043
561 JOINT INJURY 92 0.0043
562 ACUTE MYOCARDIAL INFARCTION 127 0.0043
563 PRODUCT USE IN UNAPPROVED INDICATION 1064 0.0043
564 UPPER RESPIRATORY TRACT INFECTION 198 0.0043
565 WEIGHT DECREASED 1192 0.0043
566 DECREASED ACTIVITY 46 0.0043
567 ANXIETY 1213 0.0043
568 DYSTONIA 82 0.0042
569 BURNING SENSATION 296 0.0042
570 HYPOTENSION 846 0.0042
571 DIABETES MELLITUS 321 0.0042
572 DIARRHOEA 2715 0.0042
573 OSTEONECROSIS OF JAW 104 0.0042
574 HYPOAESTHESIA 625 0.0042
575 BLOOD MAGNESIUM DECREASED 36 0.0042
576 DENTAL CARIES 46 0.0042
577 EMOTIONAL DISTRESS 503 0.0042
578 INFLAMMATION 214 0.0041
579 ARTERIOSCLEROSIS 39 0.0041
580 BRONCHOSPASM 59 0.0041
581 NECK PAIN 231 0.0041
582 BLOOD PRESSURE SYSTOLIC INCREASED 80 0.0041
583 HEPATIC CIRRHOSIS 77 0.0041
584 ABDOMINAL PAIN UPPER 841 0.0041
585 HEMIPARESIS 69 0.0041
586 GLOMERULAR FILTRATION RATE DECREASED 50 0.0041
587 LYMPHADENOPATHY 144 0.0041
588 DEFORMITY 38 0.0041
589 RESPIRATORY RATE INCREASED 36 0.0041
590 EJECTION FRACTION DECREASED 63 0.0040
591 ROTATOR CUFF SYNDROME 52 0.0040
592 BRAIN OEDEMA 51 0.0040
593 GASTROINTESTINAL DISORDER 361 0.0040
594 PALLOR 109 0.0040
595 TOOTH FRACTURE 44 0.0040
596 TOOTHACHE 72 0.0040
597 DRUG TOXICITY 54 0.0040
598 OEDEMA PERIPHERAL 482 0.0040
599 PANIC ATTACK 144 0.0039
600 RENAL IMPAIRMENT 331 0.0039
601 HEART RATE IRREGULAR 89 0.0039
602 INTERVERTEBRAL DISC PROTRUSION 86 0.0039
603 LOCALISED INFECTION 95 0.0039
604 HAEMOGLOBIN DECREASED 403 0.0039
605 FLUID OVERLOAD 57 0.0039
606 RASH PRURITIC 212 0.0039
607 HYPERCALCAEMIA 48 0.0039
608 FEAR 104 0.0039
609 OFF LABEL USE 3383 0.0039
610 CARPAL TUNNEL SYNDROME 54 0.0039
611 HYPERKALAEMIA 135 0.0038
612 FLATULENCE 217 0.0038
613 DEAFNESS 100 0.0038
614 BLOOD CALCIUM DECREASED 43 0.0038
615 RASH GENERALISED 99 0.0038
616 PULMONARY FIBROSIS 73 0.0038
617 CHILLS 445 0.0038
618 NERVE INJURY 42 0.0038
619 CONJUNCTIVITIS 70 0.0038
620 BLOOD UREA INCREASED 63 0.0038
621 CARDIO-RESPIRATORY ARREST 157 0.0038
622 WOUND INFECTION 41 0.0037
623 VERTIGO 228 0.0037
624 WEIGHT FLUCTUATION 39 0.0037
625 QUALITY OF LIFE DECREASED 50 0.0037
626 TOXICITY TO VARIOUS AGENTS 628 0.0037
627 SPEECH DISORDER 195 0.0037
628 EYE INFECTION 42 0.0037
629 RHABDOMYOLYSIS 155 0.0037
630 DEPRESSED LEVEL OF CONSCIOUSNESS 147 0.0037
631 DEHYDRATION 495 0.0037
632 EATING DISORDER 79 0.0037
633 ADRENAL INSUFFICIENCY 45 0.0037
634 HEPATIC STEATOSIS 69 0.0037
635 THROAT TIGHTNESS 100 0.0037
636 MUSCLE RIGIDITY 44 0.0037
637 HEART RATE DECREASED 129 0.0037
638 SLEEP APNOEA SYNDROME 70 0.0037
639 RIB FRACTURE 75 0.0036
640 PAIN IN JAW 103 0.0036
641 HAEMORRHAGE 379 0.0036
642 BLOOD IRON DECREASED 43 0.0036
643 DIPLOPIA 94 0.0036
644 PRODUCT TASTE ABNORMAL 49 0.0036
645 ATRIAL FIBRILLATION 352 0.0036
646 CAESAREAN SECTION 42 0.0036
647 BONE DENSITY DECREASED 113 0.0036
648 SOMNOLENCE 726 0.0036
649 HEADACHE 2259 0.0036
650 LETHARGY 207 0.0036
651 URTICARIA 601 0.0036
652 CARDIOMYOPATHY 53 0.0036
653 WOUND 100 0.0036
654 INFUSION SITE PAIN 46 0.0036
655 HAEMATOMA 92 0.0035
656 IMPAIRED QUALITY OF LIFE 51 0.0035
657 MUSCULAR WEAKNESS 402 0.0035
658 DRUG INEFFECTIVE 4656 0.0035
659 URINARY TRACT INFECTION 600 0.0035
660 CYSTITIS 112 0.0035
661 PHARYNGITIS STREPTOCOCCAL 38 0.0035
662 MENTAL IMPAIRMENT 85 0.0035
663 JOINT RANGE OF MOTION DECREASED 47 0.0035
664 DRUG EXPOSURE DURING PREGNANCY 119 0.0035
665 DECREASED APPETITE 812 0.0035
666 PERIPHERAL COLDNESS 48 0.0035
667 POST PROCEDURAL COMPLICATION 67 0.0035
668 FEELING COLD 97 0.0035
669 SKIN REACTION 49 0.0035
670 DELUSION 54 0.0035
671 RESTLESSNESS 127 0.0035
672 CARDIOVASCULAR DISORDER 88 0.0035
673 SEASONAL ALLERGY 49 0.0035
674 HYPOTHERMIA 35 0.0035
675 PERICARDITIS 58 0.0034
676 PAIN 2119 0.0034
677 IMPAIRED HEALING 113 0.0034
678 HYPOCALCAEMIA 65 0.0034
679 RESPIRATORY TRACT INFECTION 89 0.0034
680 EAR DISCOMFORT 35 0.0034
681 WHEEZING 202 0.0034
682 PREGNANCY 68 0.0034
683 CYTOKINE RELEASE SYNDROME 68 0.0034
684 ANGINA PECTORIS 97 0.0034
685 DIZZINESS 1685 0.0034
686 GASTROINTESTINAL PAIN 37 0.0034
687 BLOOD POTASSIUM DECREASED 101 0.0034
688 FEEDING DISORDER 68 0.0033
689 GAIT INABILITY 112 0.0033
690 DYSPNOEA EXERTIONAL 126 0.0033
691 MALAISE 1467 0.0033
692 ACUTE MYELOID LEUKAEMIA 52 0.0033
693 FOOT FRACTURE 63 0.0033
694 MENSTRUATION DELAYED 36 0.0033
695 HYPOAESTHESIA ORAL 50 0.0033
696 COVID-19 PNEUMONIA 39 0.0033
697 LIMB DISCOMFORT 102 0.0033
698 TREMOR 546 0.0033
699 ASTHENIA 1234 0.0033
700 GASTROINTESTINAL HAEMORRHAGE 274 0.0033
701 PULMONARY HYPERTENSION 68 0.0033
702 PULMONARY CONGESTION 43 0.0033
703 GLOSSODYNIA 73 0.0033
704 BRAIN FOG 51 0.0033
705 WRIST FRACTURE 39 0.0033
706 HYPERTENSION 687 0.0032
707 HAEMATURIA 111 0.0032
708 PALPITATIONS 379 0.0032
709 MULTIPLE FRACTURES 53 0.0032
710 PRODUCTIVE COUGH 154 0.0032
711 TASTE DISORDER 65 0.0032
712 CRYING 116 0.0032
713 RETCHING 68 0.0032
714 EYELID OEDEMA 37 0.0032
715 CHEST DISCOMFORT 325 0.0032
716 EYE PAIN 179 0.0032
717 ORTHOSTATIC HYPOTENSION 55 0.0032
718 APATHY 46 0.0032
719 EYE SWELLING 117 0.0031
720 CYST 39 0.0031
721 PRESYNCOPE 76 0.0031
722 GAIT DISTURBANCE 598 0.0031
723 LUNG DISORDER 153 0.0031
724 OROPHARYNGEAL PAIN 289 0.0031
725 CHEST PAIN 578 0.0031
726 MYALGIA 530 0.0031
727 DEPRESSION 709 0.0031
728 SENSORY DISTURBANCE 50 0.0031
729 HYPOGLYCAEMIA 151 0.0031
730 LYMPHOCYTE COUNT DECREASED 55 0.0031
731 RASH 1351 0.0031
732 SYNCOPE 310 0.0031
733 ORAL DISCOMFORT 43 0.0031
734 MUSCULOSKELETAL PAIN 162 0.0031
735 UPPER GASTROINTESTINAL HAEMORRHAGE 52 0.0031
736 RESPIRATORY TRACT CONGESTION 49 0.0031
737 MASS 43 0.0031
738 MYOCARDIAL ISCHAEMIA 35 0.0031
739 HYPERGLYCAEMIA 112 0.0031
740 COMA 146 0.0031
741 PULMONARY OEDEMA 137 0.0031
742 PNEUMONIA 987 0.0030
743 MUSCULOSKELETAL CHEST PAIN 47 0.0030
744 DEPRESSED MOOD 160 0.0030
745 DYSKINESIA 123 0.0030
746 EXTRAPYRAMIDAL DISORDER 75 0.0030
747 TOOTH DISORDER 67 0.0030
748 APHONIA 42 0.0030
749 RED BLOOD CELL COUNT DECREASED 86 0.0030
750 HEPATIC FUNCTION ABNORMAL 112 0.0030
751 PRODUCT USE COMPLAINT 47 0.0030
752 PRURITUS 1145 0.0030
753 LUNG INFECTION 46 0.0030
754 HEART RATE INCREASED 293 0.0030
755 BLOOD CREATINE PHOSPHOKINASE INCREASED 85 0.0029
756 BLOOD URINE PRESENT 56 0.0029
757 SCIATICA 47 0.0029
758 DYSSTASIA 86 0.0029
759 MUSCLE ATROPHY 37 0.0029
760 DISCOMFORT 178 0.0029
761 TENDON RUPTURE 36 0.0029
762 AGITATION 214 0.0029
763 DISEASE PROGRESSION 343 0.0029
764 THINKING ABNORMAL 54 0.0029
765 BLOOD PRESSURE INCREASED 440 0.0029
766 DISEASE RECURRENCE 136 0.0029
767 EPILEPSY 87 0.0028
768 HEPATIC ENZYME INCREASED 194 0.0028
769 MEDICATION ERROR 158 0.0028
770 NEPHROLITHIASIS 130 0.0028
771 INTENTIONAL PRODUCT MISUSE 248 0.0028
772 DYSPNOEA 1594 0.0028
773 TRANSIENT ISCHAEMIC ATTACK 95 0.0028
774 LOCAL SWELLING 49 0.0028
775 BALANCE DISORDER 242 0.0028
776 ANOREXIA 36 0.0028
777 MOVEMENT DISORDER 89 0.0028
778 PAIN IN EXTREMITY 815 0.0028
779 LYMPHOPENIA 39 0.0028
780 PNEUMONITIS 75 0.0028
781 BLOOD PRESSURE DECREASED 183 0.0028
782 TOOTH LOSS 57 0.0027
783 ARTHRALGIA 1142 0.0027
784 THERAPEUTIC PRODUCT EFFECT DECREASED 123 0.0027
785 BACK PAIN 637 0.0027
786 METASTASES TO BONE 45 0.0027
787 ERUCTATION 53 0.0027
788 SINUS CONGESTION 37 0.0027
789 MENTAL DISORDER 119 0.0027
790 SKIN DISCOLOURATION 125 0.0027
791 ABDOMINAL DISCOMFORT 455 0.0027
792 TREATMENT NONCOMPLIANCE 147 0.0027
793 CONTUSION 258 0.0027
794 COGNITIVE DISORDER 125 0.0027
795 FEELING HOT 164 0.0027
796 CEREBRAL HAEMORRHAGE 95 0.0027
797 TYPE 2 DIABETES MELLITUS 89 0.0026
798 PERIPHERAL SWELLING 405 0.0026
799 MUSCLE SPASMS 481 0.0026
800 METASTASES TO LIVER 46 0.0026
801 SINUSITIS 268 0.0026
802 URINARY INCONTINENCE 77 0.0026
803 JOINT STIFFNESS 68 0.0026
804 BLOOD POTASSIUM INCREASED 42 0.0026
805 SUICIDAL IDEATION 236 0.0026
806 MIGRAINE 246 0.0026
807 IMPAIRED WORK ABILITY 55 0.0026
808 BRADYCARDIA 136 0.0026
809 VIRAL INFECTION 85 0.0026
810 COLD SWEAT 45 0.0026
811 STOMATITIS 154 0.0025
812 GASTRIC ULCER 48 0.0025
813 SINUS DISORDER 50 0.0025
814 FATIGUE 1960 0.0025
815 EMOTIONAL DISORDER 77 0.0025
816 SEIZURE 288 0.0025
817 PROTEINURIA 47 0.0025
818 MUSCLE TIGHTNESS 40 0.0025
819 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 445 0.0025
820 PERICARDIAL EFFUSION 57 0.0025
821 THIRST 44 0.0025
822 OXYGEN SATURATION DECREASED 138 0.0025
823 VISION BLURRED 337 0.0025
824 NEUTROPHIL COUNT DECREASED 100 0.0025
825 CONVULSION 140 0.0024
826 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 57 0.0024
827 THERAPEUTIC RESPONSE SHORTENED 81 0.0024
828 BLOOD SODIUM DECREASED 46 0.0024
829 NASAL CONGESTION 143 0.0024
830 MOBILITY DECREASED 174 0.0024
831 IMMUNODEFICIENCY 36 0.0024
832 PLATELET COUNT DECREASED 257 0.0024
833 INSOMNIA 642 0.0024
834 PSYCHOMOTOR HYPERACTIVITY 40 0.0024
835 BRONCHITIS 178 0.0024
836 PRURITUS GENERALISED 52 0.0024
837 MUSCULOSKELETAL DISCOMFORT 41 0.0024
838 GASTROENTERITIS VIRAL 43 0.0024
839 BASAL CELL CARCINOMA 37 0.0024
840 POOR QUALITY SLEEP 51 0.0024
841 ARTHRITIS 186 0.0024
842 LOSS OF CONSCIOUSNESS 302 0.0024
843 VAGINAL HAEMORRHAGE 102 0.0023
844 SKIN DISORDER 78 0.0023
845 LABORATORY TEST ABNORMAL 69 0.0023
846 ASTHMA 264 0.0023
847 CEREBRAL INFARCTION 57 0.0023
848 ACTIVITIES OF DAILY LIVING IMPAIRED 46 0.0023
849 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 111 0.0023
850 BLOOD COUNT ABNORMAL 35 0.0023
851 SEDATION 60 0.0023
852 VISUAL IMPAIRMENT 283 0.0023
853 HYPERHIDROSIS 293 0.0023
854 ILLNESS 234 0.0023
855 COUGH 635 0.0023
856 SKIN EXFOLIATION 191 0.0023
857 JOINT SWELLING 273 0.0023
858 VISUAL ACUITY REDUCED 74 0.0022
859 NIGHTMARE 77 0.0022
860 EAR INFECTION 59 0.0022
861 RHINORRHOEA 143 0.0022
862 EPISTAXIS 165 0.0022
863 WEIGHT INCREASED 493 0.0022
864 THROAT IRRITATION 98 0.0022
865 PRODUCT PRESCRIBING ERROR 52 0.0022
866 RESPIRATORY DISORDER 65 0.0022
867 DISTURBANCE IN ATTENTION 117 0.0022
868 BLINDNESS 88 0.0022
869 POLLAKIURIA 90 0.0022
870 ARRHYTHMIA 102 0.0022
871 RENAL DISORDER 100 0.0021
872 LIMB INJURY 58 0.0021
873 FLUSHING 217 0.0021
874 HERPES ZOSTER 122 0.0021
875 BONE PAIN 124 0.0021
876 HYPOACUSIS 91 0.0021
877 SURGERY 123 0.0021
878 HIP FRACTURE 67 0.0021
879 RESPIRATORY ARREST 56 0.0020
880 INCORRECT PRODUCT ADMINISTRATION DURATION 44 0.0020
881 IRRITABILITY 122 0.0020
882 DISABILITY 40 0.0020
883 SNEEZING 45 0.0020
884 HYPOTHYROIDISM 64 0.0020
885 BLOOD TRIGLYCERIDES INCREASED 35 0.0020
886 BLOOD PRESSURE ABNORMAL 39 0.0020
887 TARDIVE DYSKINESIA 55 0.0019
888 WHITE BLOOD CELL COUNT DECREASED 211 0.0019
889 FEELING ABNORMAL 466 0.0019
890 SYSTEMIC LUPUS ERYTHEMATOSUS 69 0.0019
891 COVID-19 338 0.0019
892 CONTRAINDICATED PRODUCT ADMINISTERED 58 0.0019
893 UPPER LIMB FRACTURE 38 0.0019
894 CARDIAC FAILURE CONGESTIVE 150 0.0019
895 ROAD TRAFFIC ACCIDENT 78 0.0019
896 KIDNEY INFECTION 36 0.0018
897 ABNORMAL DREAMS 50 0.0018
898 FIBROMYALGIA 44 0.0018
899 AGEUSIA 45 0.0018
900 FALL 596 0.0018
901 PRODUCT PRESCRIBING ISSUE 39 0.0018
902 ABASIA 44 0.0018
903 GASTRIC DISORDER 61 0.0018
904 LACRIMATION INCREASED 53 0.0018
905 HOT FLUSH 132 0.0017
906 PRODUCT USE ISSUE 329 0.0017
907 NASOPHARYNGITIS 322 0.0017
908 DRY EYE 87 0.0017
909 INTENTIONAL DOSE OMISSION 49 0.0017
910 FLUID RETENTION 87 0.0017
911 MOOD ALTERED 46 0.0017
912 MEMORY IMPAIRMENT 230 0.0017
913 EYE DISORDER 54 0.0016
914 DRUG EFFECT INCOMPLETE 59 0.0016
915 INFLUENZA 181 0.0016
916 ARTHROPATHY 89 0.0016
917 ABNORMAL BEHAVIOUR 63 0.0016
918 CARDIAC FAILURE 126 0.0016
919 SUICIDE ATTEMPT 93 0.0015
920 INFLUENZA LIKE ILLNESS 126 0.0015
921 ALOPECIA 297 0.0015
922 HYPERSOMNIA 43 0.0015
923 DIABETIC KETOACIDOSIS 36 0.0015
924 PSORIASIS 195 0.0015
925 AMNESIA 97 0.0015
926 ACCIDENTAL OVERDOSE 54 0.0015
927 AGGRESSION 73 0.0015
928 URINARY RETENTION 48 0.0014
929 ECZEMA 75 0.0014
930 DEMENTIA 40 0.0014
931 THERAPEUTIC RESPONSE DECREASED 86 0.0014
932 OSTEONECROSIS 46 0.0014
933 CATARACT 83 0.0014
934 PRODUCT DOSE OMISSION ISSUE 409 0.0014
935 MYOCARDIAL INFARCTION 239 0.0014
936 EYE PRURITUS 46 0.0014
937 UNEVALUABLE EVENT 103 0.0014
938 RHEUMATOID ARTHRITIS 152 0.0013
939 ACNE 101 0.0013
940 NERVOUSNESS 69 0.0013
941 DEVICE DISLOCATION 57 0.0013
942 OVERDOSE 282 0.0013
943 CEREBROVASCULAR ACCIDENT 216 0.0013
944 SKIN BURNING SENSATION 91 0.0013
945 ANGER 42 0.0012
946 INTERSTITIAL LUNG DISEASE 60 0.0012
947 HEAD INJURY 39 0.0012
948 MYELOSUPPRESSION 44 0.0012
949 NEOPLASM PROGRESSION 42 0.0012
950 PSORIATIC ARTHROPATHY 49 0.0012
951 ILL-DEFINED DISORDER 73 0.0012
952 DERMATITIS ATOPIC 63 0.0012
953 THERAPEUTIC RESPONSE UNEXPECTED 53 0.0012
954 DRY SKIN 156 0.0012
955 INTENTIONAL OVERDOSE 74 0.0012
956 OCULAR HYPERAEMIA 53 0.0011
957 MOOD SWINGS 35 0.0011
958 MALIGNANT NEOPLASM PROGRESSION 111 0.0011
959 EYE IRRITATION 61 0.0011
960 ADVERSE DRUG REACTION 95 0.0011
961 THERAPY CESSATION 53 0.0010
962 PRODUCT DOSE OMISSION 67 0.0010
963 HOSPITALISATION 156 0.0010
964 MULTIPLE SCLEROSIS 48 0.0010
965 CARDIAC DISORDER 92 0.0010
966 INCORRECT DOSE ADMINISTERED 222 0.0010
967 DEVICE BREAKAGE 39 0.0010
968 BLOOD GLUCOSE DECREASED 46 0.0010
969 DEATH 821 0.0010
970 NEOPLASM MALIGNANT 62 0.0009
971 BLOOD GLUCOSE INCREASED 166 0.0009
972 COMPLETED SUICIDE 71 0.0009
973 SKIN IRRITATION 38 0.0008
974 DEVICE ISSUE 71 0.0008
975 THERAPY INTERRUPTED 56 0.0008
976 UNDERDOSE 57 0.0008
977 INJECTION SITE BRUISING 60 0.0008
978 ADVERSE EVENT 69 0.0007
979 DRUG EFFECT DECREASED 39 0.0007
980 INJECTION SITE SWELLING 53 0.0007
981 INJECTION SITE PAIN 201 0.0007
982 INJECTION SITE ERYTHEMA 81 0.0007
983 PRODUCT SUBSTITUTION ISSUE 37 0.0006
984 MULTIPLE SCLEROSIS RELAPSE 42 0.0006
985 INJECTION SITE PRURITUS 41 0.0006
986 INJECTION SITE REACTION 42 0.0006
987 NO ADVERSE EVENT 103 0.0006
988 DRUG WITHDRAWAL SYNDROME 49 0.0006
989 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 39 0.0005
990 PRODUCT QUALITY ISSUE 73 0.0005
991 INJECTION SITE HAEMORRHAGE 41 0.0005
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 102 0.0005
993 BREAST CANCER 44 0.0005
994 DRUG DOSE OMISSION 73 0.0004
995 DRUG DEPENDENCE 65 0.0004